Global Menotropin Market 2012-2016

Global Menotropin Market 2012-2016

Category : Healthcare

request-discount
TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Menotropin market to grow at a CAGR of 1.315 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of infertility cases. The Global Menotropin market has also been witnessing an increasing number of awareness programs on the prevention and treatment of infertility. However, the adverse side effects of menotropins could pose a challenge to the growth of this market. 
TechNavio's report, the Global Menotropin Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Menotropin market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space Ferring Pharmaceuticals Inc. and Merck Serono S.A.
The other vendors mentioned in the report are Angelini Farmaceutica S.A., Bharat Serums and Vaccines Ltd., Emcure Pharmaceuticals Ltd., Fuji Yakuhin Co. Ltd., GP-Pharm S.A., LG Life Sciences India Pvt. Ltd., Mochida Pharmaceutical Co. Ltd., Neiss Labs Ltd., Sanzyme Ltd., Win Medicare Pvt. Ltd., and Zydus Cadila Healthcare Ltd.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Menotropin Drug Profile

06.1 Product Description

06.2 Mechanism of Action

07. Market Landscape

Market Size and Forecast

07.1 Five Forces Analysis

08. Geographical Segmentation

09. Countries with Lowest and Highest Fertility Rates

10. Rate of Incidence and Prevalence

11. Vendor Landscape

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges


17. Market Trends

18. Key Vendor Analysis


18.1 Angelini Farmaceutica S.A.

Business Overview

SWOT Analysis

18.2 Ferring Pharmaceuticals Inc.

Business Overview

Key Information

SWOT Analysis

18.3 Merck Serono S.A.

Business Overview

Key Information

SWOT Analysis

18.4 Mochida Pharmaceutical Co. Ltd.

Business Overview

Key Information

SWOT Analysis

18.5 Zydus Cadila Healthcare Ltd.

Business Overview

Key Information

SWOT Analysis

19. Other Reports in this Series



List of Exhibits:

Exhibit 1: Market Research Methodology

Exhibit 2: Global Menotropin Market 2012-2016 (US$ million)

Exhibit 3: Global Menotropin Market by Geographical Segmentation 2012

Exhibit 4: Global Menotropin Market by Geographical Segmentation 2012-2016 (percentage)

Exhibit 5: Fertility Rates cross Major Countries (Number of Births per Women) 2006-2011

Exhibit 6: Countries with Lowest Fertility Rates 2012

Exhibit 7: Countries with Highest Fertility Rates 2012

Exhibit 8: Business Segmentation of Angelini Farmaceutica S.A.

Exhibit 9: Business Segmentation of Ferring Pharmaceuticals Inc.

Exhibit 10: Business Segmentation of Merck Serono S.A.

Exhibit 11: Business Segmentation of Mochida Pharmaceutical Co. Ltd.

Exhibit 12: Business Segmentation of Zydus Cadila Healthcare Ltd.



Enquiry Before Buy